[Form 4] Stride, Inc. Insider Trading Activity

Rhea-AI Filing Summary

James Jeaho Rhyu, who serves as Stride, Inc.'s Chief Executive Officer and a Director, reported equity changes on a Form 4 related to awards that vested on 09/18/2025. The filing shows the acquisition of 58,395 shares of common stock due to vesting of a performance award granted on 09/06/2022, and a related entry reflecting 58,395 shares tied to restricted stock rights that vested based on achievement of stock-price compound annual growth rate targets through 09/15/2025. To cover tax withholding upon vesting, 45,957 shares were withheld by the issuer at an effective price of $138.54, resulting in reported beneficial ownership figures of 777,186, 764,748 and 823,143 across the reported lines. The form is signed by an attorney-in-fact on 09/19/2025.

Positive

• Performance award vested indicating the executive met the award's performance criteria resulting in acquisition of 58,395 shares
• Long-term incentive metrics achieved as restricted stock rights vested based on compound annual growth rate conditions through 09/15/2025

Negative

• Significant share withholding of 45,957 shares to cover taxes reduced the net shares received by the executive
• Disposition recorded at $138.54 (withheld shares) which reduced the reporting person’s gross share receipt

Insights

Corporate Governance Expert

TL;DR: CEO equity awards vested at target performance, with shares withheld for taxes; this is a routine executive compensation settlement.

The filing documents the vesting of performance-based and restricted stock rights for the CEO and Director. The grant originally dated 09/06/2022 met vesting criteria measured through 09/15/2025, producing an acquisition of 58,395 shares. Standard withholding of 45,957 shares occurred to satisfy tax obligations; the withholding was executed at an implied price of $138.54. These transactions reflect compensation mechanics rather than open-market trading and do not indicate additional purchases or sales beyond tax-related dispositions.

Executive Compensation Analyst

TL;DR: Achievement of performance targets triggered sizable equity settlement; withholding reduced net share receipt.

The report clarifies that a performance award granted in 2022 vested at an above-target threshold, delivering 58,395 shares to the reporting person. The simultaneous withholding of 45,957 shares to cover tax liabilities materially reduced the net shares delivered. The entries include both non-derivative share acquisitions and the conversion of restricted stock rights tied to CAGR stock-price targets, illustrating common long-term incentive plan settlement and tax withholding procedures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rhyu James Jeaho

(Last) (First) (Middle)

11720 PLAZA AMERICA DRIVE

9TH FLOOR

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stride, Inc. [ LRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/18/2025		M(1)		58,395	A	$0	764,748	D
Common Stock	09/18/2025		A(1)		58,395	A	$0	823,143	D
Common Stock	09/18/2025		F(2)		45,957	D	$138.54	777,186	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Right	(3)	09/18/2025		M			58,395	(3)	09/15/2025	Common Stock	58,395	$0	0	D

Explanation of Responses:

1. Represents the acquisition of shares of Common Stock in connection with the vesting at above target threshold of the performance award originally granted on September 6, 2022.

2. Represents the number of shares withheld by the Issuer upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the vesting date.

3. Each restricted stock right represents a contingent right to receive one share of Stride common stock. The restricted stock rights vested based on the achievement of certain compound annual growth rates in the price of the Company's common stock between the award date and September 15, 2025, subject to earlier vesting in certain circumstances described in the applicable award agreement.

	/s/ John C. Grothaus, Attorney-in-fact	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stride (LRN) CEO James Jeaho Rhyu report on Form 4 dated 09/18/2025?

The filing reports the vesting and acquisition of 58,395 shares from a performance award and the vesting of corresponding restricted stock rights tied to CAGR targets through 09/15/2025.

How many shares were withheld to cover taxes upon vesting?

The issuer withheld 45,957 shares upon vesting to satisfy the executive’s withholding tax obligations.

What price is associated with the withheld/disposed shares?

The withheld/disposed shares are recorded at a price of $138.54.

What was the source and grant date of the vested award?

The performance award that vested was originally granted on 09/06/2022 and vested at an above-target threshold.

Who signed the Form 4 and when was it signed?

The form was signed by John C. Grothaus, Attorney-in-fact on 09/19/2025.